IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kiniksa Pharmaceuticals Inte

CUSIP: G62694109 | 1 institutional holders

Quarters

Q3 2024Q2 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

Scout Investments, Inc.222,779
0.2% of portfolio›$5.9M
StyleTurnoverLocationFiled
Scout Investments, Inc.
222,779$5.9M0.2%GrowthLowKansas City, MO2024-11-12